DRKS00013124已完成未知
A randomized controlled trial for investigating a novel integrated care concept (NICC) for patients suffering from chronic cardiovascular disease: CardioCare MV - CardioCare MV
niversitätsmedizin Rostock0 个研究点目标入组 964 人开始时间: 2017年10月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 964
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1. Heart failure (I50, NYHA II-IV) or atrial fibrillation (I48, EHRA II-IV) or resistant hypertension (I10-15, = 3 antihypertensive medicines from different drug classes, SBP > 140 /90mmHg or = 4 antihypertensives irrespective of the blood pressure, with at least one drug being a diuretic).
- •2. Member of health insurance company AOK Nordost or Techniker Krankenkasse (TK).
- •3. Inscription to integrated care contract with the health insurance company.
- •4. Residence in Mecklenburg-Vorpommern.
- •5. Age = 18 years.
- •6. Written informed consent.
排除标准
- •1. Pregnancy, suspected pregnancy or breast-feeding period.
- •2. Participation in another clinical trial up to 30 days before inclusion in this trial.
- •3. Cognitive deficits: patients need to be able to read and understand German language as presented on a tablet.
- •4. Chronic kidney disease requiring dialysis or creatinine clearance < 15 ml/min.
研究者
相似试验
进行中（未招募）
1 期
A randomised, controlled trial to investigate the effect of a four/six week intensified pharmacological treatment for schizophrenia, major depressive disorder and bipolar depression compared to treatment as usual in subjects who had a first-time treatment failure on their first-line treatment.Schizophrenia, schizoaffective disorder, schizophreniform disorder, major depressive disorder or bipolar disorder type I and II (currently in a depressive episode)MedDRA version: 20.0Level: HLTClassification code: 10039620Term: Schizoaffective and schizophreniform disorders Class: 10037175MedDRA version: 21.1Level: LLTClassification code: 10081270Term: Major depressive disorder Class: 10037175MedDRA version: 20.0Level: PTClassification code: 10039626Term: Schizophrenia Class: 100000004873MedDRA version: 21.1Level: LLTClassification code: 10004936Term: Bipolar depression Class: 10037175CTIS2022-502185-24-00niversity Medical Center Utrecht1,254
进行中（未招募）
1 期
A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for bipolar depression compared to treatment as usual in subjects who had a first-time treatment failure on their first-line treatment.Bipolar depressionMedDRA version: 21.1Level: LLTClassification code: 10004936Term: Bipolar depression Class: 10037175CTIS2023-506605-19-00niversitair Medisch Centrum Utrecht423
已完成
4 期
A study to investigate the real-life use of the Vannair SMART regime in adult asthma (the SMART study).AsthmaRespiratory - AsthmaACTRN12610000515099Medical Research Institute of New Zealand300
进行中（未招募）
1 期
A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for major depressive disorder compared to treatment as usual in subjects who had a first-time treatment failure on their first-line treatment.Major depressive disorderMedDRA version: 21.1Level: LLTClassification code: 10081270Term: Major depressive disorder Class: 10037175CTIS2023-506617-21-00niversitair Medisch Centrum Utrecht418
进行中（未招募）
4 期
A clinical study to investigate whether third-line treatments work better as a second-line treatment for people diagnosed with schizophreniaSchizophrenia, schizoaffective disorder or schizophreniform disorderMental and Behavioural DisordersISRCTN83479057niversity Medical Center Utrecht418